| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |